𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Dominant-Negative Mutation of p53 Tumor Suppressor Gene in Endometrial Carcinoma

✍ Scribed by Noriaki Sakuragi; Atsuko Hirai; Mitsuhiro Tada; Hideto Yamada; Ritsu Yamamoto; Seiichiro Fujimoto; Tetsuya Moriuchi


Book ID
112248715
Publisher
Elsevier Science
Year
2001
Tongue
English
Weight
101 KB
Volume
83
Category
Article
ISSN
0090-8258

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


P53 tumor suppressor gene mutations in h
✍ Sanjay Katiyar; Bipin C. Dash; Varsha Thakur; Raj C. Guptan; Shiv K. Sarin; Bhud πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 English βš– 158 KB πŸ‘ 3 views

BACKGROUND. Specific mutations of the p53 tumor suppressor gene in hepatocellular carcinoma (HCC) have been reported from several parts of the world, but to the authors' knowledge to date the status of this gene has not been studied in HCC patients in India, where HCC is one of the major cancers and

p53 gene mutations in human endometrial
✍ John I. Risinger; Georgette A. Dent; Diane Ignar-Trowbridge; John A. McLachlan; πŸ“‚ Article πŸ“… 1992 πŸ› John Wiley and Sons 🌐 English βš– 403 KB

## Abstract Although carcinoma of the uterine endometrium is the most frequently diagnosed malignancy of the female reproductive tract, the molecular genetic features of this tumor have yet to be described in significant detail. Since mutations of the __p53__ tumor suppressor gene are the single mo

Mutations of p53 tumor-suppressor gene i
✍ Norifumi Naka; Yasuhiko Tomita; Hirofumi Nakanishi; Nobuhito Araki; Tadashi Hong πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 French βš– 50 KB πŸ‘ 3 views

Transgenic mice deficient for the p53 gene were reported to frequently develop angiosarcoma (AS), suggesting that alterations in the gene are associated with tumorigenesis of AS. However, little is known about genetic changes, including p53 gene alterations, in human AS because of its rarity. We ana

Functional analysis of p53 gene and the
✍ Noriaki Sakuragi; Hidemichi Watari; Yasuhiko Ebina; Ritsu Yamamoto; Eric Steiner πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 French βš– 182 KB πŸ‘ 1 views

## Abstract In addition to the loss of function, mutant p53 can possess a dominant‐negative effect on wild‐type p53 and may also exert gain‐of‐function activity. It is not clear whether the functional status of __p53__ mutation contributes to differences in outcome in endometrial cancer. We collect

Involvement of p53 gene mutations in hum
✍ Tsuyoshi Honda; Hidenori Kato; Toshiro Imamura; Tomonao Gima; Jun-Ichi Nishida; πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 French βš– 1019 KB

Mutations in the p53 gene are associated with a wide variety of human malignancies. Point mutation in one allele and loss of the remaining one generally lead to inactivation of p53 protein. A high frequency of allelic losses corresponding to the I7p 13.3 region that contained the p53 gene sequence